Interestingly, many lines of evidence suggest that TIGIT is important in reducing adaptive and innate immunity towards malignancies, and anti-TIGIT mAbs have shown promising results in the field of lung cancer [1,10,11]. The gene discussed is TIGIT; the disease is lung cancer.